Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors

NCT06770764 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Metastatic Solid Tumors

Interventions

DRUG: ODC-IL2

Sponsor

Trutino Biosciences Inc.